Eli Lilly rolled out positive Phase 2 results for lepodisiran, a therapy targeting lipoprotein(a)—that genetic party crasher ...
Comfortable and durable workwear is perfect for cold ORs, clinics, and outdoor weather conditions AUSTIN, TX / ACCESS ...
Q4 2024 Earnings Call Transcript March 31, 2025 Celcuity Inc. misses on earnings expectations. Reported EPS is $-0.85 EPS, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback